Harper Molly — SEC Form 4 filings
SEC reporting owner CIK 1871470. 12 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-02-16 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 49,579 shares, $1,093,870 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 32.
- Largest priced transaction: sale of 17,500 shares @ $22.00 ($385,000) in CATALYST PHARMACEUTICALS, INC., filed 2024-11-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. (CPRX) | Director | 12 | — | 5 legs · 49,579 sh · $1,093,870 | 32 |
Form 4 filings — Harper Molly
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to issuer (D): 3,694 @ $31.50 · Disposition to issuer (D): 12,500 (derivative) @ $0 · Disposition to issuer (D): 20,000 (derivative) @ $0 · Disposition to issuer (D): 15,000 (derivative) @ $0 · Disposition to issuer (D): 29,524 (derivative) @ $0 · Disposition to issuer (D): 23,248 (derivative) @ $0 · +4 more | EDGAR |
| 2025-12-30 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,334 · Option exercise (M): 1,334 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 20,000 @ $5.78 · Sale (S): 15,527 @ $23.20 · Sale (S): 4,473 @ $23.73 · Sale (S): 6,746 @ $23.06 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 947 · Grant/award (A): 18,115 (derivative) @ $0 · Grant/award (A): 5,468 (derivative) @ $0 · Option exercise (M): 947 (derivative) @ $0 | EDGAR |
| 2025-02-19 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
| 2024-12-31 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,333 · Option exercise (M): 1,333 (derivative) @ $0 | EDGAR |
| 2024-12-11 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 1,413 · Option exercise (M): 1,413 (derivative) @ $0 | EDGAR |
| 2024-11-29 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 17,500 @ $5.78 · Sale (S): 17,500 @ $22 · Option exercise (M): 17,500 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/award (A): 23,248 (derivative) @ $0 · Grant/award (A): 2,841 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Sale (S): 5,333 @ $16.30 | EDGAR |
| 2024-02-16 | 4 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Option exercise (M): 4,000 · Option exercise (M): 4,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1871470 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →